(Q36834159)

16 August 2017

1 reference

title

Pulmonary hypertension: current diagnosis and treatment (English)

1 reference

16 August 2017

main subject

pulmonary hypertension

1 reference

Stephan Rosenkranz

1

1 reference

16 August 2017

publication date

4 June 2007

1 reference

Clinical Research in Cardiology

16 August 2017

published in

1 reference

16 August 2017

volume

96

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

527-541

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-007-0526-8

16 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0526-8

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

12 December 2020

The registry of the international society for heart and lung transplantation: nineteenth official report-2002.

1 reference

12 December 2020

Hemodynamic monitoring during sexual intercourse and physical exercise in a patient with chronic heart failure and pulmonary hypertension

1 reference

12 December 2020

Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension

1 reference

12 December 2020

Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment

1 reference

12 December 2020

Tricuspid annular displacement predicts survival in pulmonary hypertension

1 reference

12 December 2020

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

1 reference

12 December 2020

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients

1 reference

12 December 2020

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

1 reference

12 December 2020

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis

1 reference

12 December 2020

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

1 reference

12 December 2020

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan

1 reference

12 December 2020

Assessment of right ventricular function using two-dimensional echocardiography

1 reference

12 December 2020

The role of exercise testing in the management of pulmonary arterial hypertension

1 reference

12 December 2020

Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

1 reference

12 December 2020

Diagnosis and differential assessment of pulmonary arterial hypertension

1 reference

12 December 2020

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

1 reference

12 December 2020

Inhaled iloprost for severe pulmonary hypertension

1 reference

12 December 2020

Pulmonary Arterial Hypertension

1 reference

12 December 2020

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

12 December 2020

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

1 reference

12 December 2020

Doppler echocardiographic index for assessment of global right ventricular function

1 reference

12 December 2020

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension

1 reference

12 December 2020

An unusual cause of dyspnoea and pulmonary hypertension in a patient with a symptom history of 20 years--"Just do it again"

1 reference

12 December 2020

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

12 December 2020

Severe pulmonary hypertension and chronic obstructive pulmonary disease

1 reference

12 December 2020

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

1 reference

12 December 2020

Sitaxsentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Hemodynamic characterization of patients with severe emphysema.

1 reference

12 December 2020

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

12 December 2020

Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide

1 reference

12 December 2020

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension

1 reference

12 December 2020

Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data

1 reference

12 December 2020

A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension

1 reference

12 December 2020

Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension

1 reference

12 December 2020

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

1 reference

12 December 2020

Beraprost therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension

1 reference

12 December 2020

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.

1 reference

12 December 2020

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

1 reference

12 December 2020

Pulmonary Arterial Hypertension

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension

1 reference

12 December 2020

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

1 reference

12 December 2020

Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study.

1 reference

12 December 2020

[Guidelines to long-term oxygen therapy]

1 reference

12 December 2020

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

1 reference

12 December 2020

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

1 reference

12 December 2020

Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension

1 reference

12 December 2020

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

12 December 2020

Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension

1 reference

12 December 2020

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Interventional and surgical modalities of treatment for pulmonary arterial hypertension

1 reference

12 December 2020

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

12 December 2020

Clinical classification of pulmonary hypertension.

1 reference

12 December 2020

Pulmonary arterial hypertension: the key role of echocardiography

1 reference

12 December 2020

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

12 December 2020

Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop

1 reference

12 December 2020

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

12 December 2020

Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension

1 reference

12 December 2020

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

1 reference

12 December 2020

Survival with first-line bosentan in patients with primary pulmonary hypertension.

1 reference

12 December 2020

Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension

1 reference

12 December 2020

Cellular and molecular pathobiology of pulmonary arterial hypertension

1 reference

12 December 2020

10.1007/S00392-007-0526-8

Identifiers

DOI

1 reference

16 August 2017

1 reference